MeSH term
Frequency | Condition_Probility | Animals | 30 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Comparative Study | 11 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Monocytes/*metabolism | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 19 | 0.0 |
Up-Regulation | 4 | 0.0 |
CHO Cells | 2 | 0.0 |
Cell Line | 16 | 0.0 |
Hamsters | 4 | 0.0 |
Humans | 66 | 0.0 |
Macromolecular Substances | 5 | 0.0 |
*Membrane Glycoproteins | 13 | 1.0 |
Research Support, Non-U.S. Gov't | 53 | 0.0 |
Antibodies, Monoclonal/pharmacology | 3 | 0.0 |
Antigens, CD3/metabolism | 2 | 1.0 |
Cells, Cultured | 10 | 0.0 |
Enzyme Activation | 3 | 0.0 |
Jurkat Cells | 2 | 0.0 |
Phosphorylation | 3 | 0.0 |
Rats | 7 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Antigens, CD/genetics/*metabolism | 2 | 2.0 |
Cloning, Molecular | 8 | 0.0 |
Female | 8 | 0.0 |
Mice | 13 | 0.0 |
Pregnancy | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Adult | 7 | 0.0 |
Aged | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
*Antigens, CD | 4 | 0.0 |
Immunophenotyping | 5 | 0.0 |
Male | 7 | 0.0 |
Middle Aged | 4 | 0.0 |
Antigens, CD/*genetics | 6 | 2.0 |
Antigens, Differentiation, T-Lymphocyte/*genetics | 5 | 9.0 |
Base Sequence | 15 | 0.0 |
Child, Preschool | 3 | 0.0 |
Molecular Sequence Data | 18 | 0.0 |
Blotting, Western | 4 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Integrin alpha3beta1 | 4 | 12.0 |
Integrin alpha6beta1 | 2 | 10.0 |
*Membrane Proteins | 8 | 0.0 |
Protein Conformation | 2 | 0.0 |
Tumor Cells, Cultured | 10 | 0.0 |
Adolescent | 5 | 0.0 |
Antigens, Differentiation, T-Lymphocyte/genetics | 2 | 6.0 |
Membrane Glycoproteins/*genetics | 2 | 0.0 |
Platelet Membrane Glycoproteins/genetics | 2 | 15.0 |
Antigens, CD/metabolism | 3 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Amino Acid Sequence | 17 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Precipitin Tests | 5 | 0.0 |
Antigens, CD/*metabolism | 3 | 0.0 |
Flow Cytometry | 8 | 0.0 |
Fluorescence | 2 | 0.0 |
Macrophage-1 Antigen/metabolism | 2 | 2.0 |
Up-Regulation/drug effects | 2 | 0.0 |
Gene Expression | 6 | 0.0 |
Antigens, CD/*physiology | 4 | 1.0 |
Cell Communication | 3 | 1.0 |
Immunohistochemistry | 5 | 0.0 |
Antigens, CD/immunology | 4 | 0.0 |
Antigens, CD3/immunology | 2 | 0.0 |
Cell Adhesion/immunology | 2 | 1.0 |
*Lymphocyte Activation | 2 | 0.0 |
Antibodies, Monoclonal/immunology | 7 | 0.0 |
Antigens, CD/immunology/*metabolism | 3 | 6.0 |
Epitopes/immunology | 2 | 0.0 |
Integrins/*metabolism | 2 | 1.0 |
Protein Binding/drug effects | 2 | 0.0 |
Signal Transduction/*immunology | 3 | 0.0 |
Cell Differentiation | 3 | 0.0 |
*Proto-Oncogene Proteins | 10 | 0.0 |
Transfection | 4 | 0.0 |
Antigens, CD/analysis | 2 | 0.0 |
Energy Transfer | 2 | 3.0 |
Fluorescent Dyes | 2 | 0.0 |
HLA Antigens/analysis | 2 | 0.0 |
Immunoglobulins, Fab/immunology | 2 | 1.0 |
Models, Biological | 2 | 0.0 |
Antibodies | 2 | 0.0 |
Child | 2 | 0.0 |
Infant | 2 | 0.0 |
Phenotype | 5 | 0.0 |
Membrane Proteins/*genetics | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Antigens, CD/immunology/metabolism | 2 | 3.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
Calcium/metabolism | 4 | 0.0 |
N-Formylmethionine Leucyl-Phenylalanine/pharmacology | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 3 | 0.0 |
*Cell Adhesion | 2 | 1.0 |
*Signal Transduction | 3 | 0.0 |
Antibodies, Monoclonal | 5 | 0.0 |
L Cells (Cell Line) | 2 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
*Antigens, Neoplasm | 5 | 2.0 |
Antigens, Differentiation, T-Lymphocyte/*physiology | 2 | 1.0 |
Lymphoma, B-Cell/pathology | 3 | 15.0 |
*Multigene Family | 4 | 0.0 |
Phylogeny | 2 | 0.0 |
Antigens, CD/*analysis | 6 | 0.0 |
Antigens, Surface/analysis | 2 | 0.0 |
B-Lymphocytes/*immunology | 5 | 0.0 |
Lymphocyte Activation/immunology | 3 | 0.0 |
T-Lymphocytes/*immunology | 4 | 0.0 |
Antigens, Neoplasm/analysis | 3 | 0.0 |
Cattle | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Interferon Type II/pharmacology | 3 | 0.0 |
Lymphocyte Activation/*immunology | 2 | 0.0 |
Antigens, CD/analysis/*physiology | 2 | 7.0 |
Interleukin-4/pharmacology | 2 | 0.0 |
DNA/genetics | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Species Specificity | 3 | 0.0 |
T-Lymphocytes/immunology | 3 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Mice, Inbred DBA | 2 | 0.0 |
Blotting, Southern | 3 | 0.0 |
Multigene Family | 2 | 0.0 |
Peptide Mapping | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Antigens, Differentiation/analysis | 2 | 0.0 |
HLA-DR Antigens/analysis | 2 | 0.0 |
Glycosylation | 2 | 0.0 |
Antigens, Differentiation/*genetics | 2 | 1.0 |
Glycoproteins/*genetics | 2 | 1.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
